Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies
Nigrostriatal dopaminergic degeneration in alpha-synucleinopathies is indirectly reflected by low dopamine transporter (DaT) uptake through [123I]FP-CIT-SPECT. Bulk magnetic susceptibility (χ) in the substantia nigra, from MRI-based quantitative susceptibility mapping (QSM), is a potential biomarker of nigrostriatal degeneration, however, QSM cannot disentangle paramagnetic (e.g. iron) and diamagnetic (e.g. myelin) sources. Using the susceptibility source-separation technique DECOMPOSE, paramagnetic component susceptibility (PCS) and diamagnetic component susceptibility (DCS) were studied in prodromal and overt alpha-synucleinopathies, and their relationships with DaT-SPECT specific binding ratio (SBR) and clinical scores. 78 participants were included (23 controls, 30 prodromal and 25 overt alpha-synucleinopathies). Prodromal patients were subdivided into groups with positive or negative DaT-SPECT (SBR Z-scores below or above -1, respectively). Correlations of putamen and caudate SBR Z-scores with PCS and DCS in the substantia nigra, putamen, and caudate were investigated. Increased PCS was observed in the substantia nigra of prodromal alpha-synucleinopathy patients with positive DaT-SPECT compared to controls and prodromal patients with negative DaT-SPECT. SBR Z-scores in the putamen correlated with increased PCS in the substantia nigra and reduced |DCS| in the putamen, which may reflect dopaminergic degeneration ascribable to iron accumulation and nigrostriatal neuron axonal loss, respectively.
Authors
- Stefano Raffa
- Luca Roccatagliata (ORCID: https://orcid.org/0000-0001-8029-3947)
- Francesco Calizzano
- Elisa Pelosin (ORCID: https://orcid.org/0000-0002-9880-2241)
- Laura Avanzino (ORCID: https://orcid.org/0000-0001-6286-1509)
- Laura Falcitano (ORCID: https://orcid.org/0000-0002-8258-2184)
- Andrea Diociasi (ORCID: https://orcid.org/0000-0002-5986-0406)
- Pietro Mattioli (ORCID: https://orcid.org/0000-0003-2563-5830)
- Oliver Kiersnowski (ORCID: https://orcid.org/0000-0001-6016-0514)
- Mauro Costagli (ORCID: https://orcid.org/0000-0001-9073-1082)
- Federico Massa (ORCID: https://orcid.org/0000-0001-5667-204X)
- Matteo Pardini (ORCID: https://orcid.org/0000-0002-4740-1982)
- Dario Arnaldi (ORCID: https://orcid.org/0000-0001-6823-6069)
- Silvia Daniela Morbelli (ORCID: https://orcid.org/0000-0002-7833-6095)
- Beatrice Orso (ORCID: https://orcid.org/0000-0001-9983-7940)
- Lucia Argenti (ORCID: https://orcid.org/0009-0008-7444-1411)
- Chunlei Liu (ORCID: https://orcid.org/0000-0001-8816-4832)
- Mattia Losa (ORCID: https://orcid.org/0009-0008-2942-1307)
Institutions
- Ospedale Policlinico San Martino (IT)
- University of Turin (IT)
- University of Genoa (IT)
- University of California, Berkeley (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1038/s41598-024-83593-z
- Citations
- 2
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- European Commission
- Ministero della Salute